Publicação

Delineation of pathogenomic insights of breast cancer in young women

Ver documento

Detalhes bibliográficos
Resumo:The prognosis of breast cancer (BC) in young women (BCYW) aged ≤40 years tends to be poorer than that in older patients due to aggressive phenotypes, late diagnosis, distinct biologic, and poorly understood genomic features of BCYW. Considering the estimated predisposition of only approximately 15% of the BC population to BC-promoting genes, the underlying reasons for an increased occurrence of BCYW, at large, cannot be completely explained based on general risk factors for BC. This underscores the need for the development of next-generation of tissue- and body fluid-based prognostic and predictive biomarkers for BCYW. Here, we identified the genes associated with BCYW with a particular focus on the age, intrinsic BC subtypes, matched normal or normal breast tissues, and BC laterality. In young women with BC, we observed dysregulation of age-associated cancer-relevant gene sets in both cancer and normal breast tissues, sub-sets of which substantially affected the overall survival (OS) or relapse-free survival (RFS) of patients with BC and exhibited statically significant correlations with several gene modules associated with cellular processes such as the stroma, immune responses, mitotic progression, early response, and steroid responses. For example, high expression of COL1A2, COL5A2, COL5A1, NPY1R, and KIAA1644 mRNAs in the BC and normal breast tissues from young women correlated with a substantial reduction in the OS and RFS of BC patients with increased levels of these exemplified genes. Many of the genes upregulated in BCYW were overexpressed or underexpressed in normal breast tissues, which might provide clues regarding the potential involvement of such genes in the development of BC later in life. Many of BCYW-associated gene products were also found in the extracellular microvesicles/exosomes secreted from breast and other cancer cell-types as well as in body fluids such as urine, saliva, breast milk, and plasma, raising the possibility of using such approaches in the development of non-invasive, predictive and prognostic biomarkers. In conclusion, the findings of this study delineated the pathogenomics of BCYW, providing clues for future exploration of the potential predictive and prognostic importance of candidate BCYW molecules and research strategies as well as a rationale to undertake a prospective clinical study to examine some of testable hypotheses presented here. In addition, the results presented here provide a framework to bring out the importance of geographical disparities, to overcome the current bottlenecks in BCYW, and to make the next quantum leap for sporadic BCYW research and treatment.
Autores principais:Paul, Aswathy Mary
Outros Autores:George, Bijesh; Saini, Sunil; Pillai, Madhavan Radhakrishna; Toi, Masakazu; Costa, Luis; Kumar, Rakesh
Assunto:Early breast cancer Genomics Predictive biomarkers Prognosis Transcriptomics Young women
Ano:2022
País:Portugal
Tipo de documento:artigo
Tipo de acesso:acesso aberto
Instituição associada:Universidade de Lisboa
Idioma:inglês
Origem:Repositório da Universidade de Lisboa
_version_ 1866811177047162880
author Paul, Aswathy Mary
author2 George, Bijesh
Saini, Sunil
Pillai, Madhavan Radhakrishna
Toi, Masakazu
Costa, Luis
Kumar, Rakesh
author2_role author
author
author
author
author
author
author_facet Paul, Aswathy Mary
George, Bijesh
Saini, Sunil
Pillai, Madhavan Radhakrishna
Toi, Masakazu
Costa, Luis
Kumar, Rakesh
author_role author
contributor_name_str_mv Repositório Científico de Acesso Aberto da ULisboa
country_str PT
creators_json_txt [{\"Person.name\":\"Paul, Aswathy Mary\"},{\"Person.name\":\"George, Bijesh\"},{\"Person.name\":\"Saini, Sunil\"},{\"Person.name\":\"Pillai, Madhavan Radhakrishna\"},{\"Person.name\":\"Toi, Masakazu\"},{\"Person.name\":\"Costa, Luis\",\"Person.identifier.orcid\":\"0000-0002-4782-7318\"},{\"Person.name\":\"Kumar, Rakesh\"}]
datacite.contributors.contributor.contributorName.fl_str_mv Repositório Científico de Acesso Aberto da ULisboa
datacite.creators.creator.creatorName.fl_str_mv Paul, Aswathy Mary
George, Bijesh
Saini, Sunil
Pillai, Madhavan Radhakrishna
Toi, Masakazu
Costa, Luis
Kumar, Rakesh
datacite.date.Accepted.fl_str_mv 2022-01-01T00:00:00Z
datacite.date.available.fl_str_mv 2022-07-18T16:29:17Z
datacite.date.embargoed.fl_str_mv 2022-07-18T16:29:17Z
datacite.rights.fl_str_mv http://purl.org/coar/access_right/c_abf2
datacite.subjects.subject.fl_str_mv Early breast cancer
Genomics
Predictive biomarkers
Prognosis
Transcriptomics
Young women
datacite.titles.title.fl_str_mv Delineation of pathogenomic insights of breast cancer in young women
dc.contributor.none.fl_str_mv Repositório Científico de Acesso Aberto da ULisboa
dc.creator.none.fl_str_mv Paul, Aswathy Mary
George, Bijesh
Saini, Sunil
Pillai, Madhavan Radhakrishna
Toi, Masakazu
Costa, Luis
Kumar, Rakesh
dc.date.Accepted.fl_str_mv 2022-01-01T00:00:00Z
dc.date.available.fl_str_mv 2022-07-18T16:29:17Z
dc.date.embargoed.fl_str_mv 2022-07-18T16:29:17Z
dc.format.none.fl_str_mv application/pdf
dc.identifier.none.fl_str_mv http://hdl.handle.net/10451/53844
dc.language.none.fl_str_mv eng
dc.publisher.none.fl_str_mv MDPI
dc.rights.cclincense.fl_str_mv http://creativecommons.org/licenses/by/4.0/
dc.rights.none.fl_str_mv http://purl.org/coar/access_right/c_abf2
dc.subject.none.fl_str_mv Early breast cancer
Genomics
Predictive biomarkers
Prognosis
Transcriptomics
Young women
dc.title.fl_str_mv Delineation of pathogenomic insights of breast cancer in young women
dc.type.none.fl_str_mv http://purl.org/coar/resource_type/c_6501
description The prognosis of breast cancer (BC) in young women (BCYW) aged ≤40 years tends to be poorer than that in older patients due to aggressive phenotypes, late diagnosis, distinct biologic, and poorly understood genomic features of BCYW. Considering the estimated predisposition of only approximately 15% of the BC population to BC-promoting genes, the underlying reasons for an increased occurrence of BCYW, at large, cannot be completely explained based on general risk factors for BC. This underscores the need for the development of next-generation of tissue- and body fluid-based prognostic and predictive biomarkers for BCYW. Here, we identified the genes associated with BCYW with a particular focus on the age, intrinsic BC subtypes, matched normal or normal breast tissues, and BC laterality. In young women with BC, we observed dysregulation of age-associated cancer-relevant gene sets in both cancer and normal breast tissues, sub-sets of which substantially affected the overall survival (OS) or relapse-free survival (RFS) of patients with BC and exhibited statically significant correlations with several gene modules associated with cellular processes such as the stroma, immune responses, mitotic progression, early response, and steroid responses. For example, high expression of COL1A2, COL5A2, COL5A1, NPY1R, and KIAA1644 mRNAs in the BC and normal breast tissues from young women correlated with a substantial reduction in the OS and RFS of BC patients with increased levels of these exemplified genes. Many of the genes upregulated in BCYW were overexpressed or underexpressed in normal breast tissues, which might provide clues regarding the potential involvement of such genes in the development of BC later in life. Many of BCYW-associated gene products were also found in the extracellular microvesicles/exosomes secreted from breast and other cancer cell-types as well as in body fluids such as urine, saliva, breast milk, and plasma, raising the possibility of using such approaches in the development of non-invasive, predictive and prognostic biomarkers. In conclusion, the findings of this study delineated the pathogenomics of BCYW, providing clues for future exploration of the potential predictive and prognostic importance of candidate BCYW molecules and research strategies as well as a rationale to undertake a prospective clinical study to examine some of testable hypotheses presented here. In addition, the results presented here provide a framework to bring out the importance of geographical disparities, to overcome the current bottlenecks in BCYW, and to make the next quantum leap for sporadic BCYW research and treatment.
dirty 0
eu_rights_str_mv openAccess
format article
fulltext.url.fl_str_mv https://repositorio.ulisboa.pt/bitstreams/f00708a9-11b6-4bab-9769-6cfebbc592d6/download
id ul_632f827dfdb63c0a4c194487ea843c1a
identifier.url.fl_str_mv http://hdl.handle.net/10451/53844
instacron_str ul
institution Universidade de Lisboa
instname_str Universidade de Lisboa
language eng
network_acronym_str ul
network_name_str Repositório da Universidade de Lisboa
oai_identifier_str oai:repositorio.ulisboa.pt:10451/53844
organization_str_mv urn:organizationAcronym:ul
person_str_mv Paul, Aswathy Mary
George, Bijesh
Saini, Sunil
Pillai, Madhavan Radhakrishna
Toi, Masakazu
Costa, Luis
Costa, Luis
https://www.ciencia-id.pt/041E-4ADE-FB64
041E-4ADE-FB64
http://orcid.org/0000-0002-4782-7318
0000-0002-4782-7318
Kumar, Rakesh
publishDate 2022
publisher.none.fl_str_mv MDPI
reponame_str Repositório da Universidade de Lisboa
repository_id_str urn:repositoryAcronym:ul
service_str_mv urn:repositoryAcronym:ul
spelling engMDPIpt_PTThe prognosis of breast cancer (BC) in young women (BCYW) aged ≤40 years tends to be poorer than that in older patients due to aggressive phenotypes, late diagnosis, distinct biologic, and poorly understood genomic features of BCYW. Considering the estimated predisposition of only approximately 15% of the BC population to BC-promoting genes, the underlying reasons for an increased occurrence of BCYW, at large, cannot be completely explained based on general risk factors for BC. This underscores the need for the development of next-generation of tissue- and body fluid-based prognostic and predictive biomarkers for BCYW. Here, we identified the genes associated with BCYW with a particular focus on the age, intrinsic BC subtypes, matched normal or normal breast tissues, and BC laterality. In young women with BC, we observed dysregulation of age-associated cancer-relevant gene sets in both cancer and normal breast tissues, sub-sets of which substantially affected the overall survival (OS) or relapse-free survival (RFS) of patients with BC and exhibited statically significant correlations with several gene modules associated with cellular processes such as the stroma, immune responses, mitotic progression, early response, and steroid responses. For example, high expression of COL1A2, COL5A2, COL5A1, NPY1R, and KIAA1644 mRNAs in the BC and normal breast tissues from young women correlated with a substantial reduction in the OS and RFS of BC patients with increased levels of these exemplified genes. Many of the genes upregulated in BCYW were overexpressed or underexpressed in normal breast tissues, which might provide clues regarding the potential involvement of such genes in the development of BC later in life. Many of BCYW-associated gene products were also found in the extracellular microvesicles/exosomes secreted from breast and other cancer cell-types as well as in body fluids such as urine, saliva, breast milk, and plasma, raising the possibility of using such approaches in the development of non-invasive, predictive and prognostic biomarkers. In conclusion, the findings of this study delineated the pathogenomics of BCYW, providing clues for future exploration of the potential predictive and prognostic importance of candidate BCYW molecules and research strategies as well as a rationale to undertake a prospective clinical study to examine some of testable hypotheses presented here. In addition, the results presented here provide a framework to bring out the importance of geographical disparities, to overcome the current bottlenecks in BCYW, and to make the next quantum leap for sporadic BCYW research and treatment.application/pdfpt_PTDelineation of pathogenomic insights of breast cancer in young womenPaul, Aswathy MaryGeorge, BijeshSaini, SunilPillai, Madhavan RadhakrishnaToi, MasakazuPersonalCosta, LuisDSpacehttp://dspace.org/items/8a2ab4c6-ba86-4433-b4b7-6256d81890e5DSpacehttp://dspace.org/items/8a2ab4c6-ba86-4433-b4b7-6256d81890e5CostaLuisCiência IDhttps://www.ciencia-id.pt041E-4ADE-FB64ORCIDhttp://orcid.org0000-0002-4782-7318Kumar, RakeshHostingInstitutionOrganizationalRepositório Científico de Acesso Aberto da ULisboae-mailmailto:repositorio@reitoria.ulisboa.ptrepositorio@reitoria.ulisboa.ptDOIIsPartOf10.3390/cells111219272022-07-18T16:29:17Z20222022-01-01T00:00:00ZHandlehttp://hdl.handle.net/10451/53844http://purl.org/coar/access_right/c_abf2open accessEarly breast cancerGenomicsPredictive biomarkersPrognosisTranscriptomicsYoung women11471923 bytesliteraturehttp://purl.org/coar/resource_type/c_6501journal article2022http://creativecommons.org/licenses/by/4.0/http://purl.org/coar/access_right/c_abf2application/pdffulltexthttps://repositorio.ulisboa.pt/bitstreams/f00708a9-11b6-4bab-9769-6cfebbc592d6/downloadCells1112
spellingShingle Delineation of pathogenomic insights of breast cancer in young women
Paul, Aswathy Mary
Early breast cancer
Genomics
Predictive biomarkers
Prognosis
Transcriptomics
Young women
status SINGLETON
subject.fl_str_mv Early breast cancer
Genomics
Predictive biomarkers
Prognosis
Transcriptomics
Young women
title Delineation of pathogenomic insights of breast cancer in young women
title_full Delineation of pathogenomic insights of breast cancer in young women
title_fullStr Delineation of pathogenomic insights of breast cancer in young women
title_full_unstemmed Delineation of pathogenomic insights of breast cancer in young women
title_short Delineation of pathogenomic insights of breast cancer in young women
title_sort Delineation of pathogenomic insights of breast cancer in young women
topic Early breast cancer
Genomics
Predictive biomarkers
Prognosis
Transcriptomics
Young women
topic_facet Early breast cancer
Genomics
Predictive biomarkers
Prognosis
Transcriptomics
Young women
url http://hdl.handle.net/10451/53844
visible 1